Phillip Pang, EVP & Chief Medical Officer at Vir Biotechnology, Inc. (VIR), sold 3,321 shares at $10.24 ($34K) on 2024-02-16, disclosed to the SEC on 2024-02-16.
Seasonal sale ($34k) by EVP & Chief Medical Officer — this insider has traded VIR in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| VIR | SELL | 2023-02-28 | $238K | — | Filing → |
| VIR | SELL | 2023-02-24 | $149K | — | Filing → |
| VIR | SELL | 2023-02-21 | $142K | — | Filing → |